Considerations of sex in bioequivalence assessments: does sex affect pharmacokinetic variability between evaluation formulations?
Background: Bioequivalence assessment determines the equivalence between drug formulations and is primarily used to demonstrate that a generic product is equivalent to its reference. The sex of the drug consumer is a major consideration in bioequivalence assessment, but specific ratios or absolute c...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 81; no. 4; pp. 583 - 597 |
|---|---|
| Autores principales: | , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Apr2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |